Clinical trials
Completed Phase 4 Wet Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Barcelona Macula Foundation | 1 |
| Bayer | 1 |
| Rishi Singh | 1 |
| Seoul National University Hospital | 1 |
| University of California, Los Angeles | 1 |
| University of California, San Diego | 1 |
| Università degli Studi di Brescia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wet Macular Degeneration | 12 |
| Macular Degeneration | 7 |
| Geographic Atrophy | 5 |
| Vision Disorders | 5 |
| Choroidal Neovascularization | 4 |
| Retinal Degeneration | 2 |
| Eye Diseases | 1 |
| Neovascularization, Pathologic | 1 |
| Retinal Diseases | 1 |
| Retinal Vein Occlusion | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.